Impax Laboratories (IPXL) PT Lowered to $17 at Cowen Following Announced Deal with Amneal
Cowen lowered its price target on Impax Laboratories (NASDAQ: IPXL) to $17.00 (from $20.00) while maintaining a Market ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
